Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [T9] Hope - Alliance A021901 Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T8] Trikalinos - NCI 10479 A Phase I Dose Escalation Expansion Trial of Sunitinib Malate plus Lu 177 Dotatate in SSTR+ Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T7] Narayan - Trial in Progress A Phase 2 Study of ONC206 in Patients with Advanced Pheochromocytoma and Paraganglioma Published in 2025 Listed under Trials In Progress Download [T6] Soulen - Multicenter Phase 2 Trial of Yttrium 90 Radioembolization with Capecitabine Temozolomide for Grade 2 Liver Dominant Metastatic Neuroendocrine Tumors interim report Published in 2025 Listed under Trials In Progress Download [T6] Soulen (POSTER) - Multicenter Phase 2 Trial of Yttrium 90 Radioembolization with Capecitabine Temozolomide for Grade 2 Liver Dominant Metastatic Neuroendocrine Tumors interim report Published in 2025 Listed under Trials In Progress Download [T5] Mohamed - Trial in progress A Phase Ib II, Open label, Multi center Study of ZL 1310 in Participants with DLL3 positive Neuroendocrine Carcinomas (NECs) and other Selected Solid Tumors Published in 2025 Listed under Trials In Progress Download [T4] Chauhan - CAREFNDR Phase 3, Randomized, Placebo Controlled Study of Paltusotine in Adults With Carcinoid Syndrome Due to Well Differentiated Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T3] Chauhan - Obrixtamig (BI 764532) in relapsed refractory delta like ligand 3 (DLL3) high extrapulmonary neuroendocrine carcinoma Phase II DAREON® 5 dose expansion trial in progress Published in 2025 Listed under Trials In Progress Download [T2] Capdevila - STELLAR 311 A randomized phase 2 3 study of zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors Published in 2025 Listed under Trials In Progress Download [T1] Kunz - NETTER 3 [177Lu]Lu DOTA TATE in patients with newly diagnosed, Grade 1 2 (Ki 67 10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden Published in 2025 Listed under Trials In Progress Download [T1] Kunz (POSTER) - NETTER 3 [177Lu]Lu DOTA TATE in patients with newly diagnosed, Grade 1 2 (Ki 67 10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden Published in 2025 Listed under Trials In Progress Download [T15] Chauhan - ETCTN 10558 A Phase II Randomized Control Trial of Triapine Plus Lutetium 177 Dotatate Versus Lutetium 177 Dotatate Alone for Well Differentiated Somatostatin Receptor Positive Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T14] Li - First in Human Study of a Novel Nonpeptide Drug Conjugate (CRN09682) in Patients With Somatostatin Receptor 2 Expressing Tumors Published in 2025 Listed under Trials In Progress Download [T13] Ammabel Ynalvez - Stratification of Biochemical Response to Somatostatin Analogs in Carcinoid Syndrome Implications for Risk of Carcinoid Heart Disease Published in 2025 Listed under Trials In Progress Download [T12] Pruitt - A Prospective Observational Study of GLP 1 and GLP 1 GIP Receptor Agonists in Patients with Well Differentiated Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T12] Pruitt (POSTER) - A Prospective Observational Study of GLP 1 and GLP 1 GIP Receptor Agonists in Patients with Well Differentiated Neuroendocrine Tumors Published in 2025 Listed under Trials In Progress Download [T11] Chauhan - A Phase 1 Trial of the Oncolytic Virus SVV 001 with Nivolumab and Ipilimumab in Patients with High Grade Neuroendocrine Neoplasms Published in 2025 Listed under Trials In Progress Download [T10] Chauhan - NET RETREAT a CCTG SWOG Phase II Study of 177Lutetium Dotatate Retreatment vs Standard of Care in Metastatic GEPNET Patients Published in 2025 Listed under Trials In Progress Download [P9] Nwankwo - Demographic and Survival Outcomes in Early Onset Pancreatic Neuroendocrine Tumors A National Cancer Database Study Published in 2025 Listed under Population Science Download [P8] Paciorek - Clinical details of early onset neuroendocrine neoplasms differ by race and ethnicity and overall differ from typical onset Published in 2025 Listed under Population Science Download [P8] Paciorek (POSTER) - Clinical details of early onset neuroendocrine neoplasms differ by race and ethnicity and overall differ from typical onset Published in 2025 Listed under Population Science Download [P7] Thomas - Germline Pathogenic Variants Among Participants with Neuroendocrine Tumors in the Healthy Nevada Project Published in 2025 Listed under Population Science Download [P6] Meloche-Dumas - Contemporary epidemiology of gastro entero pancreatic neuroendocrine neoplasms Published in 2025 Listed under Population Science Download [P5] Xu - Treatment Decision Concerns A Latent Class Analysis in Young Onset Neuroendocrine Tumors Published in 2025 Listed under Population Science Download [P4] Sun - Survival of colorectal small cell carcinoma and comparison with colorectal adenocarcinoma Published in 2025 Listed under Population Science Download [P4] Sun (POSTER) - Survival of colorectal small cell carcinoma and comparison with colorectal adenocarcinoma Published in 2025 Listed under Population Science Download [P3] Alnajar - Higher composite Social Determinants of Health scores predict worsened survival for early stage small bowel Neuroendocrine Tumors Published in 2025 Listed under Population Science Download [P2] Zheng - Racial and ethnic disparities in US neuroendocrine tumor clinical trial enrollment over the past quarter century Published in 2025 Listed under Population Science Download [P2] Zheng (POSTER) - Racial and ethnic disparities in US neuroendocrine tumor clinical trial enrollment over the past quarter century Published in 2025 Listed under Population Science Download [P1] O’Rorke - Quality of Life and Care Experiences in a U S Multi Institutional Neuroendocrine Tumor Cohort Published in 2025 Listed under Population Science Download [P10] Chung - Racial and Gender Disparities in Neuroendocrine Tumors – A Retrospective Study Using a Single Institutional Database Published in 2025 Listed under Population Science Download [O9] Khamis - Neuroendocrine neoplasms diagnosed in the setting of inflammatory bowel disease An appraisal of published literature and proposed management algorithm Published in 2025 Listed under Other Download [O8] Baskar - Symptom burden and outcomes among patients with early onset and average onset neuroendocrine neoplasms Published in 2025 Listed under Other Download [O7] Trikalinos - Treatment Sequence in Advanced Small Bowel Neuroendocrine Neoplasms A Simulation Study Published in 2025 Listed under Other Download [O6] Vaca (POSTER) - Effect of GLP 1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide Published in 2025 Listed under Other Download [O6] Vaca - Effect of GLP 1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide Published in 2025 Listed under Other Download [O5] Graboyes - Recurrent Tympanic Paragangliomas An Overview of Institutional Experience Published in 2025 Listed under Other Download [O5] Graboyes (POSTER) - Recurrent Tympanic Paragangliomas An Overview of Institutional Experience Published in 2025 Listed under Other Download [O4] Gujarathi - Real World Outcomes with Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas Published in 2025 Listed under Other Download [O3] AbiMansour - Clinical Features and Outcomes of Small and Very Small Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Other Download [O2] Estrada - Analysis of patient selection for germline testing in early onset gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) at a single institution Published in 2025 Listed under Other Download [O2] Estrada (POSTER) - Analysis of patient selection for germline testing in early onset gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) at a single institution Published in 2025 Listed under Other Download [O1] Singh Grewal - Distinct Sociodemographic, Symptom, and HRQoL Profiles in Early Onset Neuroendocrine Tumors Insights from the NET PRO Study Published in 2025 Listed under Other Download [O13] Suresh - Peculiar Prostate Peculiarity Exploring Ectopic Cushing’s Disease in Prostate Neuroendocrine Carcinoma Published in 2025 Listed under Other Download [O12] Ueberroth - Molecular and Clinical Profiling of Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) An Analysis of the Oncology Research Information Exchange Network Database Published in 2025 Listed under Other Download [O11] Ammabel Ynalvez - Preventing Early Bioprosthetic Valve Deterioration in Carcinoid Heart Disease A Case Series and Perioperative Management Strategy Published in 2025 Listed under Other Download [O10] Soares - Expanding Access to Neuroendocrine Tumor Care Early Impact of the University of Utah NET Destination Care Program Published in 2025 Listed under Other Download [C9] Mohindroo - Somatic genomic profiling of gastrointestinal neuroendocrine tumors Implications for prognostication and therapeutic targeting Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C8] Chauhan - DAREON® 7 Phase I open label dose escalation expansion study of first line obrixtamig (BI 764532) plus chemotherapy in patients with DLL3 positive neuroendocrine carcinomas Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C7] Halfdanarson - The Hidden Cost of Enzyme Therapy Oxalate Nephropathy in a NET Patient with Pancreatic Insufficiency Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C6] Arshad - TROP2 Expression in the Gastroenteropancreatic Neuroendocrine Tumors; An analysis of 179 patients Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C5] Singh - PPM1D as a Potential Driver of Myeloid Malignancy Transformation in Neuroendocrine Tumor (NET) Pts An Underrecognized Malignant CHIPerpetrator Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C50] Battistella - Preoperative Predictors of New Onset Diabetes Mellitus Following Distal Pancreatectomy for Non functioning Pancreatic Neuroendocrine Tumours Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C4] Pirozzi - Multicenter Real World Study of Treatment Patterns in Well Differentiated Grade 3 (G3) Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C49] Said Abu Egal - Differential Expression of GLUT 1 and FASN Across Histological Grades of Pancreatic Neuroendocrine Neoplasms Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C48] Andreasi - Pancreatic Neuroendocrine Tumors with Intraductal Growth Unraveling a Rare Entity Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C47] Andreasi - Role of Surgery in Patients with G1 G2 Pancreatic Neuroendocrine Tumors and Synchronous Liver Metastases Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C46] Michelakos - Evaluating the role of postoperative long acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C45] Sachdeva - Improving Outcomes for Neuroendocrine Patients 25 year review of 1699 NET Surgical Cytoreduction Patients at a Single Institution Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C44] Wornow - Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C43] Meloche-Dumas - Mapping the evidence for surgical care of gastro entero pancreatic neuroendocrine tumors a scoping review Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C42] Chang - Risk Factors and Prognosis of Peritoneal Metastases in Small Bowel Neuroendocrine Tumor Patients Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C41] Meloche-Dumas - Survival outcomes after surgery for entero pancreatic neuroendocrine tumors a population based analysis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C40] Meloche-Dumas - Short term post operative outcomes after surgery for entero pancreatic neuroendocrine tumors (NETs) a population based analysis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C3] Mohamed - Investigator Assessed Disease Progression in a Phase 2 Study of Paltusotine in Patients with Neuroendocrine Tumors and Carcinoid Syndrome Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C39] Laderian - Primary Tumor Resection Is Associated With Improved Survival in Metastatic GI NETs A Retrospective Study in the Bronx, NY Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C38] Shah - Association of Surgical Intervention with 30 Day Re admission and Outcomes in Patients Hospitalized for Small Bowel Neuroendocrine Tumor Related Obstruction Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C37] Hallet - International expert consensus on perioperative management of carcinoid crisis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C36] Chang - The Natural History of Small Bowel Neuroendocrine Tumor (SBNET) Metastases Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C35] Hallet - Care of Neuroendocrine Tumors the Collaborative of Surgical Teams for NeuroEndocrine Tumors (CUTNETs) Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C34] Goa - Outcomes of Peptide Receptor Radionuclide Therapy in Patients with Pheochromocytoma and Paraganglioma A Center of Excellence Experience Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah (POSTER) - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C32] Cass - Incidence of Peripheral Inserted Central Line Complications with Administration of 177Lutetium Dotatate Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C30] Sztangret - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C30] Sztangret (POSTER) - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C2] Mohindroo - Prognostic Significance of MEN1, ATRX, and DAXX Mutations in Pancreatic Neuroendocrine Tumors Treated with CAPTEM Insights from a Multicenter Cohort Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C29] Mittra - Liver directed therapy for metastatic neuroendocrine carcinoma and grade 3 well differentiated neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan (POSTER) - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch (POSTER) - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman (POSTER) - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C24] Nicolas - First line Treatment with [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) in patients with NETs a SwissNET Registry Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C23] Fricke - Efficacy and safety of [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) for the treatment of neuroendocrine tumors (NETs) – a systematic literature review (SLR) and meta analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C22] Ghanta - Systematic Literature Review and Radiomics Quality Assessment for Lung, Adrenal, Thyroid and Pituitary Neuroendocrine Tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali (POSTER) - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C20] Chauhan - Multi center NCI sponsored phase 1 study of triapine in combination with 177Lu dotatate in patients with progressive well differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C1] Capdevila Castillon - An ongoing phase 1 trial of obrixtamig in patients with extrapulmonary neuroendocrine carcinomas with high or low DLL3 expression Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C19] Halfdanarson - [212Pb]VMT alpha NET for advanced SSTR+ NETs safety and preliminary efficacy results from cohorts 1 and 2 of the dose escalation phase Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye (POSTER) - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C17] Nicolas - 61Cu NODAGA LM3 versus 68Ga DOTATOC in the same patients with neuroendocrine tumors Preliminary results of the Phase I II COPPER PET in NET Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C16] Strosberg - Phase 2 Study of Targeted Alpha Therapy 212Pb DOTAMTATE in Patients with Advanced Gastroenteropancreatic (GEP) NETs Previously Treated with PRRT Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C15] Maluccio - Long term Follow up of PRRT Naïve Patients with GEP NETs Treated with Targeted Alpha Therapy 212Pb DOTAMTATE in the Phase 2 ALPHAMEDIX 02 Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C14] Capdevila Castillon - Efficacy of 177Lu edotreotide vs everolimus in patients with grade 1 or grade 2 GEP NETs Phase 3 COMPETE trial (post hoc subgroup analyses) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler (POSTER) - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
